The anticancer activity of bovine lactoferrin is reduced by deglycosylation and it follows a different pathway in cervix and colon cancer cells

Diana A. Ramírez‐Sánchez,Adrián Canizalez‐Román,Nidia León‐Sicairos,Gaspar Pérez Martínez,Gaspar Pérez Martínez

DOI: https://doi.org/10.1002/fsn3.4020

IF: 3.5529

2024-03-09

Food Science & Nutrition

Abstract:The native glycosylation state of bovine lactoferrin (bLF) is required for the inhibition of growth of cervix (HeLa) and colon (Caco‐2) cancer cells by blocking Akt phosphorylation. The response of Caco‐2 and HeLa cells to bLF involves different signal transduction intermediates possibly following different receptor/signaling pathways. bLF is endocytosed by caveolin‐1‐mediated internalization and glycan residues are essential for the interaction with both cell lines. Bovine lactoferrin (bLF) is a glycosylated protein with purported beneficial properties. The aim of this work was to determine the role of bLF glycosylation in the adhesion, internalization, and growth inhibition of cancer cells. The viability of cervix (HeLa) and colon (Caco‐2) cancer cells (MTT assay and epifluorescence microscopy) was inhibited by bLF, while deglycosylated bLF (bLFdeg) had no effect. Adhesion to cell surfaces was quantified by immunofluorescence assay and showed that bLF was able to bind more efficiently to both cell lines than bLFdeg. Microscopic observations indicated that bLF glycosylation favored bLF binding to epithelial cells and that it was endocytosed through caveolin‐1‐mediated internalization. In addition, the mechanism of action of bLF on cancer cell proliferation was investigated by determining the amount of phosphorylated intermediates of signaling pathways such as epidermal growth factor receptor (EGFR), extracellular signal‐regulated kinase (ERK) and protein kinase B (known as Akt). Chemoluminescence immunoassay of phosphorylated intermediates showed that bLF inhibited Akt phosphorylation, consistent with its growth inhibiting activity. This assay also indicated that the bLF receptor/signaling pathways may be different in the two cell lines, Caco‐2 and HeLa. This work confirmed the effect of glycosylated bLF in inhibiting cancer cell growth and that glycosylation is required for optimal surface adhesion, internalization, and inhibition of the ERK/Akt pathway of cell proliferation through glycosylated cell surface receptors.

food science & technology